Skip to main content
. 2021 Jul 8;23(8):811–822. doi: 10.1016/j.neo.2021.06.008

Table 1.

Summary of all patients enrolled in IB-DNQ + RT FOSCC Trial.

Patient Number Breed Age (y) Sexa Geographic Location (State) Tumor Location NQO1 Score Tumor Response (%)
1 DSH/Siamese 14.3 M Pacific Northwest (MT) Lingual 3 -15
2 DSH 18.9 F Midwest (IL) Maxilla 3 -40
3 DMH 13.8 F Midwest (MN) Maxilla/Mandible 2 0
4 DSH 12.7 F Southeast (VA) Maxilla 2 25
5 DLH 14.3 M South Central (MO) Lingual 3 5
6 DSH 16.6 F Midwest (IL) Mandible 1 1
7 DSH 16.8 M Midwest (IL) Mandible 2 -56
8 DSH 12.2 M Midwest (IL) Mandible 2 -27
9 DSH/Siamese 12.6 F Northeast (NY) Mandible 2 -13
10 DSH 13.0 M Midwest (MI) Mandible 2 -37
11 DSH 9.3 M Southwest (AZ) Maxilla 2 -15
12 DSH 16.3 F Midwest (IL) Mandible 2 -9
13 DSH 15.6 F Midwest (IL) Maxilla 1 12
14 Maine Coon 12.8 M South Central (TX) Mandible n.d. -16
15 DSH 12.2 M Midwest (IL) Maxilla 2 -8
16 DLH 15.1 M Midwest (IL) Mandible 2 8
17 Siamese 12.1 F Western (CO) Lingual 2 2
18 DLH 13.5 F Midwest (IL) Maxilla 2 -26
19 DSH 14.3 M South Central (KS) Maxilla 2 n/a

DSH = domestic short hair; DMH = domestic medium hair; DLH = domestic long hair. n/a = not available, patient 19 was treated with 2 doses of IB-DNQ + RT prior to being withdrawn and the owner declined a follow-up CT scan.

a

All patients were castrated/spayed felines.